A new report released by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association includes Washington University in St. Louis among the top 100 universities worldwide granted U.S. patents in 2020. The organizations released the report June 15; WashU moved up nearly 20 spots in the rankings from the prior year, to […]
DiAntonio and Milbrandt co-founded a startup biotechnology company called Disarm Therapeutics with a focus on developing treatments for neurodegenerative diseases. Global pharmaceutical maker Eli Lilly and Company recently acquired Disarm, with the goal of speeding development of new therapies for a variety of devastating neurological conditions caused by the deterioration of axons, the vital wiring of the nervous system.
“Arch Oncology’s highly differentiated approach to the development of anti-CD47 agents is a promising development in the immuno-oncology space,” said John McKearn, Ph.D., Managing Director, RiverVest Venture Partners and Chairman of the Board of Arch Oncology. “We look forward to continuing to support the Company as it develops and advances its robust pipeline of promising drug candidates, including a broad clinical program for AO-176.”
Innovative multidisciplinary research at Washington University led to development of ‘breakthrough’ device
Technology allows electrophysiologists to visualize cardiac anatomy in hands-free, real-time 3D
The Phase 1 human clinical trials of Hyderabad-based vaccine maker Bharat Biotech’s intranasal Covid-19 vaccine, codenamed BBV154, have commenced at some of the selected sites that include Hyderabad and Nagpur.
Join the WashU Office of Technology Management for this annual event honoring: 2020 Patent Awards New Faculty Startups — Caeli Vascular, Capella Imaging, Coordinate Medical Systems, DeepSight Technology, HSpeQ, Integro Theranostics & Percayai National Academy of Inventors Fellows & Senior Member — Randall Bateman, Richard Cote, Michael Diamond & Scott Hultgren Thursday, April 15, 20214:30 […]
Wugen Inc., a biotechnology company developing novel, universal allogeneic cellular therapies, today announced that it has entered into an exclusive license agreement with Washington University in St. Louis, one of the world’s leading research institutions, for the development of Wugen’s Memory Natural Killer (NK) Cell program.
St. Louis-based C2N Diagnostics has developed what it says is the first blood test to help diagnose Alzheimer’s disease. Now it has plans to take the technology global.
Pathologist Richard J. Cote, MD, the Edward Mallinckrodt Professor and head of the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, has been elected a senior member of the National Academy of Inventors (NAI). A cancer specialist, Cote has developed tools for analyzing tumor cells and predicting disease progression and response to therapy.
Encodia is a WashU faculty startup. The company is developing revolutionary tools for large-scale protein analysis to enable breakthrough insights into biology and the prevention, diagnosis, and treatment of disease.
The discovery that acute itching in eczema is linked to exposure to allergens may help them avoid things that make them itch intensely, including animals, dust, mold or certain foods.
Neurologist Randall J. Bateman, MD, virologist and immunologist Michael S. Diamond, MD, PhD, and microbiologist Scott Hultgren, PhD – all faculty members at Washington University School of Medicine in St. Louis – have been named fellows of the National Academy of Inventors, the highest professional distinction accorded solely to academic inventors.
Biotech startup Precision Virologics, which develops adenovirus-based vaccines in St. Louis, and Bharat Biotech, a manufacturing giant of vaccines, jointly obtained rights from Washington University School of Medicine in St. Louis for a novel chimp-adenovirus vaccine for COVID-19. Precision Virologics has optioned rights for USA, Europe, and Japan. Bharat has obtained a license for all other markets.
New Faculty Startups (FY July 1, 2019 – June 30, 2020) Caeli VascularCapella ImagingCoordinate Medical SystemsDeepSight TechnologyHSpeQIntegro TheranosticsPercayai The new startups will be introduced at the annual WashU Celebration of Inventors on April 15, 2021 via Zoom.
source.wustl.edu Washington University in St. Louis this year celebrates two new fellows of the National Academy of Inventors, the highest professional distinction accorded solely to academic inventors. The distinction recognizes their prolific and innovative work and their contributions, which have had tangible, positive impacts on society. The two new honorees are Jerome R. Cox Jr., […]
Developmental biologists recognized for successes in developing therapeutics Developmental biologists Irving Boime, PhD, and Douglas Covey, PhD, of Washington University School of Medicine in St. Louis, have been named senior members of the National Academy of Inventors (NAI). They are being recognized for their success in patents, licensing and commercialization, and for producing “technologies that have brought, or […]
Over the past three years, Washington University faculty patent filings through the Office of Technology Management (OTM) increased by more than 60 percent and 20 startups have been formed to license Washington University intellectual property. In 2017, 92 faculty inventors received an issued patent and, for the first time in the history of the office, it received […]